Jefferies Upgrades FuelCell Energy to Buy, Hikes Target to $24 on Major Data Center Deal
Strong upside potential vs Bloom Energy.
Strong upside potential vs Bloom Energy.
Acadia’s DAYBU gets EU positive opinion for Rett syndrome; could become first approved treatment for symptoms in Europe.
Full neutral-atom quantum stack highlighted as a major advantage.
Rademikibart offers first-mover potential in acute asthma & COPD with major Phase 2 data coming in September 2026.
Jefferies turned bullish on Tango Therapeutics as early cancer data and big market potential lifted its price target.
NASA has chosen Rocket Lab for three Electron launches starting early 2027, including PolSIR to study ice clouds and TSIS-2 to measure solar irradiance for climate and weather research.